Showing results (211-220 of 293) with videos related to
Sort By:
Pageof 30
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|August 1, 1995
In vivo pharmacology of L-159,913, a new highly potent and selective nonpeptide angiotensin II receptor antagonistR A Gabel, S D Kivlighn, G J Zingaro, et al.The American Journal of Physiology|March 11, 1995
Discovery of L-162,313: a nonpeptide that mimics the biological actions of angiotensin IIS D Kivlighn, W R Huckle, G J Zingaro, et al.Bioorganic & Medicinal Chemistry Letters|March 13, 2012
Discovery of nor-seco himbacine analogs as thrombin receptor antagonistsMariappan V Chelliah, Samuel Chackalamannil, Yan Xia, et al.Journal of Medicinal Chemistry|April 30, 1993
5-chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptaseT M Williams, T M Ciccarone, S C MacTough, et al.Journal of Medicinal Chemistry|May 29, 1992
Renin inhibitors containing C-termini derived from mercaptoheterocyclesW T Ashton, C L Cantone, L C Meurer, et al.American Journal of Hypertension|January 1, 1995
In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996S D Kivlighn, G J Zingaro, R A Gabel, et al.Journal of Medicinal Chemistry|December 24, 1993
Non-peptide angiotensin II receptor antagonists. 1. Design, synthesis, and biological activity of N-substituted indoles and dihydroindolesD S Dhanoa, S W Bagley, R S Chang, et al.Journal of Medicinal Chemistry|August 19, 1994
Triazolinone biphenylsulfonamide derivatives as orally active angiotensin II antagonists with potent AT1 receptor affinity and enhanced AT2 affinityW T Ashton, L L Chang, K L Flanagan, et al.Journal of Medicinal Chemistry|December 24, 1993
Non-peptide angiotensin II receptor antagonists. 2. Design, synthesis, and biological activity of N-substituted (phenylamino)phenylacetic acids and acyl sulfonamidesD S Dhanoa, S W Bagley, R S Chang, et al.Bioorganic & Medicinal Chemistry Letters|May 13, 2006
Design and synthesis of orally efficacious benzimidazoles as melanin-concentrating hormone receptor 1 antagonistsWen-Lian Wu, Duane A Burnett, Mary Ann Caplen, et al.Pageof 30